InsiderTrades.com logo
Kyle Moran net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Kyle Moran Biography and Net Worth

CFO of Wave Life Sciences

Kyle Moran joined Wave in 2014 as Vice President of Finance and became the Chief Financial Officer (CFO) in 2020. Kyle was responsible for establishing Wave’s finance and accounting functions and served as Principal Financial Officer through the company’s initial public offering. He then served as Senior Vice President of Supply Chain and Operations for Wave. In this capacity, he oversaw the construction of Wave’s cGMP manufacturing facility and established Wave’s cGMP operations, including manufacturing, quality, facilities, and supply chain. In 2020, Kyle expanded his responsibilities to oversee both Finance and Operations prior to being named as CFO.

Before joining Wave, he served as CFO and Chief Operating Officer of Veroha, Inc., a software company. He was also a founding partner of Context Financial Services, LLC, a boutique consulting firm that provided CFO services to companies undergoing rapid expansion or needing expert financial counsel. Prior to these roles, Kyle held senior operational and financial roles at leading global financial services firms including Zurich Scudder Investments, JPMorgan Chase, and Putnam Investments.

Kyle holds a BA in economics from Boston College and attended the Lemberg Master’s Program in international economics and finance at Brandeis University. He is a Chartered Financial Analyst.

What is Kyle Moran's net worth?

The estimated net worth of Kyle Moran is at least $178,190.77 as of September 25th, 2024. Moran owns 19,777 shares of Wave Life Sciences stock worth more than $178,191 as of March 28th. This net worth approximation does not reflect any other investments that Moran may own. Additionally, Moran receives a salary of $726,340.00 as CFO at Wave Life Sciences. Learn More about Kyle Moran's net worth.

How old is Kyle Moran?

Moran is currently 53 years old. There are 3 older executives and no younger executives at Wave Life Sciences. The oldest executive at Wave Life Sciences is Dr. Chandra Vargeese Ph.D., Chief Technology Officer, who is 63 years old. Learn More on Kyle Moran's age.

What is Kyle Moran's salary?

As the CFO of Wave Life Sciences Ltd., Moran earns $726,340.00 per year. There are 2 executives that earn more than Moran. The highest earning executive at Wave Life Sciences is Dr. Paul B. Bolno M.B.A., M.D., President, CEO & Director, who commands a salary of $1,130,000.00 per year. Learn More on Kyle Moran's salary.

How do I contact Kyle Moran?

The corporate mailing address for Moran and other Wave Life Sciences executives is 7 STRAITS VIEW #12-00 MARINA ONE EAST TOWER, SINGAPORE U0, 018936. Wave Life Sciences can also be reached via phone at (656) 236-3388 and via email at krausch@wavelifesci.com. Learn More on Kyle Moran's contact information.

Has Kyle Moran been buying or selling shares of Wave Life Sciences?

Kyle Moran has not been actively trading shares of Wave Life Sciences during the last ninety days. Most recently, Kyle Moran sold 17,146 shares of the business's stock in a transaction on Wednesday, September 25th. The shares were sold at an average price of $9.00, for a transaction totalling $154,314.00. Following the completion of the sale, the chief financial officer now directly owns 19,777 shares of the company's stock, valued at $177,993. Learn More on Kyle Moran's trading history.

Who are Wave Life Sciences' active insiders?

Wave Life Sciences' insider roster includes Paul Bolno (CEO), Chris Francis (insider), Christian Henry (Director), and Kyle Moran (CFO). Learn More on Wave Life Sciences' active insiders.

Are insiders buying or selling shares of Wave Life Sciences?

In the last twelve months, Wave Life Sciences insiders bought shares 1 times. They purchased a total of 2,791,930 shares worth more than $22,335,440.00. In the last twelve months, insiders at the sold shares 10 times. They sold a total of 697,211 shares worth more than $8,522,029.83. The most recent insider tranaction occured on March, 20th when Director Christian O Henry sold 10,500 shares worth more than $102,585.00. Insiders at Wave Life Sciences own 29.1% of the company. Learn More about insider trades at Wave Life Sciences.

Information on this page was last updated on 3/20/2025.

Kyle Moran Insider Trading History at Wave Life Sciences

See Full Table

Kyle Moran Buying and Selling Activity at Wave Life Sciences

This chart shows Kyle Moran's buying and selling at Wave Life Sciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$100k$0$100kTotal Insider BuyingTotal Insider Selling

Wave Life Sciences Company Overview

Wave Life Sciences logo
Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, a RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; siRNA clinical candidate for the treatment of obesity and other metabolic disorders; WVE-N531, a exon skipping oligonucleotide for the treatment of duchenne muscular dystrophy; and WVE-003, an antisense silencing oligonucleotide for the treatment of Huntington's disease (HD). The company has collaboration agreements with GlaxoSmithKline for the research, development, and commercialization of oligonucleotide therapeutics; Takeda Pharmaceutical Company Limited for the research, development, and commercialization of oligonucleotide therapeutics for disorders of the Central Nervous System; and Asuragen, Inc. for the development and potential commercialization of companion diagnostics for investigational allele-selective therapeutic programs targeting HD. Wave Life Sciences Ltd. was incorporated in 2012 and is based in Singapore.
Read More

Today's Range

Now: $9.01
Low: $8.91
High: $10.05

50 Day Range

MA: $10.78
Low: $9.01
High: $12.24

2 Week Range

Now: $9.01
Low: $4.25
High: $16.74

Volume

1,710,902 shs

Average Volume

1,108,939 shs

Market Capitalization

$1.38 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A